GENZYME CORP Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31)
GENZYME CORP reported Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) of $4.76 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised · last filed 2011-03-01
- GENZYME CORP tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2010-12-31 was -$43.22M, a 1061.68% decline year-over-year.
- GENZYME CORP tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2010-09-30 was $19.59M, a 1040.94% increase year-over-year.
- GENZYME CORP tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2010-06-30 was $24.77M, a 820.74% increase year-over-year.
- GENZYME CORP tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2010-03-31 was $3.62M, a 44.66% decline year-over-year.
- GENZYME CORP tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2010 was $4.76M, a 69.17% decline from fiscal 2009.
- GENZYME CORP tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2009 was $15.45M, a 74.19% decline from fiscal 2008.
- GENZYME CORP tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2008 was $59.87M.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 3 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 6 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 9 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2010-12-31 | -$43.22M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | -$23.63M derived: sum of 2 quarters · filed 2011-03-01 | $1.14M derived: sum of 3 quarters · filed 2011-03-01 | $4.76M 10-K · filed 2011-03-01 |
| 2010-09-30 | $19.59M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $44.36M derived: sum of 2 quarters · filed 2010-11-09 | $47.98M 10-Q · filed 2010-11-09 | $52.48M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-06-30 | $24.77M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $28.39M 10-Q/A · filed 2010-09-07 | $32.89M derived: sum of 3 quarters · filed 2011-03-01 | $34.60M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-03-31 | $3.62M 10-Q/A · filed 2010-05-11 | $8.12M derived: sum of 2 quarters · filed 2011-03-01 | $9.84M derived: sum of 3 quarters · filed 2011-03-01 | $12.53M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $6.21M derived: sum of 2 quarters · filed 2011-03-01 | $8.90M derived: sum of 3 quarters · filed 2011-03-01 | $15.45M 10-K · filed 2011-03-01 |
| 2009-09-30 | $1.72M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $4.41M derived: sum of 2 quarters · filed 2010-11-09 | $10.96M 10-Q · filed 2010-11-09 | $13.68M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-06-30 | $2.69M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $9.24M 10-Q/A · filed 2010-09-07 | $11.96M derived: sum of 3 quarters · filed 2011-03-01 | $43.46M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-03-31 | $6.55M 10-Q/A · filed 2010-05-11 | $9.27M derived: sum of 2 quarters · filed 2011-03-01 | $40.77M derived: sum of 3 quarters · filed 2011-03-01 | |
| 2008-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $34.22M derived: sum of 2 quarters · filed 2011-03-01 | $59.87M 10-K · filed 2011-03-01 | |
| 2008-09-30 | $31.50M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-02 | $57.15M 10-Q · filed 2009-11-02 | ||
| 2008-06-30 | $25.64M 10-Q/A · filed 2009-09-04 | |||
| 2007-12-31 | $51.04M 8-K · filed 2010-06-14 |